Healthcare Innovation Spending
HeadwindWhat this measures
Exposure to biotech and medical R&D growth.
Top names
Latest assignments · as of Oct 11, 2026, 12:00 AM
| 1 | A | Agilent Technologies, Inc. | 0.9 |
| 2 | AARD | Aardvark Therapeutics, Inc. Common Stock | 0.9 |
| 3 | ABCL | AbCellera Biologics Inc. | 0.9 |
| 4 | ABCM | Abcam plc | 0.9 |
| 5 | ABMD | Abiomed, Inc. | 0.9 |
| 6 | ABSI | Absci Corporation | 0.9 |
| 7 | ABUS | Arbutus Biopharma Corp | 0.9 |
| 8 | ACAD | ACADIA Pharmaceuticals Inc. | 0.9 |
| 9 | ADPT | Adaptive Biotechnologies Corporation | 0.9 |
| 10 | ADRX | ADARx Pharmaceuticals, Inc. | 0.9 |
Related exposures
Preview data only. Rankings and assignments can change as markets and filings update. Not investment advice.